FounderDeckPack

bims

40
Signal
BI

bims

biomed.news
Creator Toolsbiomed.news

bims has a live public website and enough signal for an early FounderDeck profile.

FounderDeck estimate
$150k
Valued 2026-06-15
Early Momentum 0 portfolios
View bims company profile

bims

bims has a live public website and enough signal for an early FounderDeck profile.

biomed.news

Is this your company?

Claim it to edit details, or request removal anytime.

Early MomentumUnclaimed ProfileEarly DiscoveryEarly BuildFeatured
FounderDeck estimate
$150k
Low confidenceValued Jun 15, 2026
0
Portfolios
Browse companies freely. New portfolio additions come exclusively from your daily pack.
Consumer appLive product
0
Momentum
0
Daily views
0
Pack saves

Momentum rises when people search, view, like, share, claim, or save this profile.

What it does

bims: Biomed News bims : Biomed News Biomed News—or “bims” for short—is a service for experts in biomedical topics as covered by PubMed The experts curate topic-specific reports . In that way, they stay up-to-date with t FounderDeck captured this company from its public website and generated an early discovery profile from the product signals visible on the page.

Who it helps

Likely aimed at creators, marketers, or media teams trying to produce, edit, publish, or grow faster.

Why it's interesting

bims shows a live product footprint, a visible market angle, and enough public signal to be worth tracking early on FounderDeck.

Profile signals

Signal Score40
Product Clarity50
Founder Momentum27
Market Potential32
Website Polish32
Monetisation48
Shareability36
Buzz39

AI-assisted scores estimated from public website information only.

FounderDeck estimate

Low confidence
$150k

FounderDeck estimated this early value from the public website, product clarity, market shape, monetisation cues, and overall signal strength visible on the page.

Valuation date: 2026-06-15. Estimate generated from public signals.

Portfolio saves

Added to 0 portfolios.

Portfolio saves do not represent ownership, equity, investment rights, IP rights, or affiliation.

Estimates are AI-generated from public information and are not financial advice or verified company valuations.